Performance Improvement

2022 RISE Performance Improvement Activity


Expires Dec 31, 2022

Program Information

CME: 20.0     MOC: 20.0

The 2022 RISE Performance Improvement Activity is an online performance improvement activity that uses evidence-based performance measures and quality improvement interventions/changes to help providers strategically identify and improve areas of patient care.

Current RISE registry users will assess their current Quality measure performance in their 2022 RISE dashboard, select measures in which they would like to improve their performance, implement changes within their practice for 90 consecutive days, and re-assess their measure performance to see if and how their performance changed. The last day providers can begin implementing changes in their practice is October 3, 2022.

Target Audience
This course is designed for rheumatologists, physicians and other healthcare providers who care for patients with rheumatic diseases and those interested or engaged in research in the field of rheumatology.

Important Notes:

  • Only current RISE registry users are eligible to participate in this activity. If you are not a current RISE registry user, contact the ACR at to learn how to participate in the registry.
  • Providers must log in and register via their own ACR account. Practice administrators cannot register via their practice administrator account as the registration must be in the providers name.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Assess their performance on Quality measures and identify which measures need performance improvement.
  • Identify and implement change(s) in their practice to improve their Quality measure performance.
  • Reassess their Quality measure performance after implementing the change(s) and summarize the outcome that resulted from implementing the change(s).

Registration Fees

This activity is complimentary.

CME and MOC Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this performance improvement activity for a maximum of 20.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

CME credit must be claimed by December 31, 2022 at 11:59 PM ET.

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MOC points must be claimed by December 31, 2022 at 11:59 PM ET.

By completing this activity you provide the ACR permission to share completion data with the ACCME and the certifying board(s).


Faculty and Disclosures

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Accredited Continuing Education (ACE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at

Nature of Financial Relationships
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial relationships with ineligible companies and the nature of financial or other relationship(s) with an ineligible company including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria, includes speakers' bureau, symposia, and expert witness
  7. Independent contractor
  8. Ownership interest
  9. Royalties
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Other financial or material support

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

View the ACR's ACCME disclosure practices

The 2022 RISE Performance Improvement Activity Planning Committee reported the following disclosures.

  • Lindsey Hunter, MS - No relevant financial relationships to disclose.
  • Janell Martin, CAE - No relevant financial relationships to disclose.
  • Virginia Reddy, MD - No relevant financial relationships to disclose.

2022 MIPS Quality Payment Program

By participating in this activity, you may be eligible to report on Improvement Activity IA_PSPA_28 - Completion of an Accredited Safety or Quality Improvement Program for 2022 MIPS. This improvement activity entails completing an accredited performance improvement continuing medical education (CME) program that addresses performance or quality improvement.

View Improvement Activity Requirements

2021 RISE Performance Improvement Activity Takeaways

Contact Info / Inquiries

© 2022 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us